Traumatic brain injury (TBI) involves both primary mechanical damage and refractory secondary injuries, resulting in high disability rate and poor prognosis. Current therapeutic strategies for TBI include surgical intervention, neuroprotective agents, moderate hypothermia therapy and spinal cord stimulation. However, most of these therapeutic approaches primarily address wound surface management rather than targeting specific pathogenic mechanisms underlying post-injury inflammation and neurodegenerative diseases, resulting in suboptimal efficacy. Consequently, novel therapeutic strategies targeting TBI pathological mechanisms are urgently needed. The endogenous cannabinoid system (ECS) exerts multifaceted neuroprotective effects in TBI by modulating neuroinflammation, inhibiting glutamate excitotoxicity and activating pathways such as phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt). Investigating the characteristics of ECS components and their related signaling pathways may yield new approaches in the development of neuroprotective drugs for TBI. Nevertheless, few ESC-targeting drugs for TBI treatment have advanced beyond preclinical or clinical trial phases. Breakthroughs in this field depend on a deeper understanding of ECS and its mechanisms in TBI. To this end, the authors reviewed researches on the composition and functions of ECS, as well as the mechanisms underlying its neuroprotective effects following TBI, aiming to provide references for the development of ECS-targeting therapies.

Objective To explore the value of inflammatory markers in predicting paroxysmal sympathetic hyperactivity(PSH)after traumatic brain injury(TBI).Methods A total of 84 TBI patients who were admitted to The Second Affiliated Hospital of Naval Medical University(Second Military Medical University)from Dec.2016 to Nov.2020 were retrospectively analyzed.They were classified into PSH group(n=41)and non-PSH group(n=43)according to whether PSH occurred during hospitalization.The baseline data and laboratory results of the 2 groups were collected and compared.Kendall correlation analysis was used to analyze the correlation between inflammatory markers and the occurrence of PSH after TBI,and receiver operating characteristic(ROC)curve was used to analyze the predictive value of inflammatory markers to PSH.Results There were no significant differences in baseline data,including age,gender,or Glasgow coma scale score,between the 2 groups(all P＞0.05).Compared with patients in the non-PSH group,the neutrophil to lymphocyte ratio(NLR),platelet to lymphocyte ratio(PLR),systemic immune-inflammation index(SII),neutrophils and leukocytes in the PSH group were significantly increased(all P＜0.05).NLR,SII and neutrophil were positively correlated with PSH(r=0.360,0.308,0.289;all P＜0.01),with the corresponding ROC area under curve values being 0.752,0.716 and 0.702,respectively.Conclusion NLR,SII and neutrophils have a value in predicting the occurrence of PSH after TBI.

Objective:To explore the effect of mesoporous silica (SiO 2) chitosan (CS) hydrogel loaded with neurotrophin-3 (NT-3) on repair of spinal cord injury. Methods:After 2%, 4%, and 6% NT-3/SiO 2 were dissolved in CS solution, they were added into β-glycerophosphate sodium solution for chemical cross-linking to obtain hydrogel patches of different NT-3 loadings. The specific surface area, pore size and pore volume of mesoporous SiO 2 nanoparticles were detected by specific surface area analyzer. The morphology of mesoporous SiO 2 nanoparticles and the pore structure of freeze-dried hydrogel were detected by scanning electron microscopy. Adhesion of the hydrogel was verified by spinal cord tissue. After the NT-3/SiO 2@CS hydrogel was placed in the medium, the concentrations of NT-3 were measured for 1 to 20 days. Neural stem cells (NSCs) were isolated from fetal rats and identified. Cell counting kit 8 (CCK-8) assay was used to detect the proliferation of NSCs treated with different concentrations of hydrogel. Immunofluorescence staining was used to detect the effects of NT-3/SiO 2@CS hydrogel on differentiation of NSCs. Twenty-four 8-week-old C57BL/6JNifdc female mice were randomly divided into a sham operation group (sham), a spinal cord injury group (SCI), a chitosan hydrogel group (CS) and a mesoporous SiO 2-loaded NT-3 hydrogel group (NT-3/SiO 2@CS). In the sham group, the muscle and skin were sutured immediately after laminectomy without spinal cord injury. The CS hydrogel and NT-3/SiO 2@CS hydrogel patches were implanted without treatment after spinal cord injury in the other 3 groups, respectively. Basso Mouse Scale (BMS) was used to evaluate the mice every 7 days for 8 weeks after modeling. The hot and cold board test and Catwalk gait analysis were performed at 8 weeks after surgery. Results:The mesoporous SiO 2 nanoparticles showed typical spherical morphology and a uniform particle size (about 160 nm). The specific surface area, pore volume and pore size of the mesoporous SiO 2 nanoparticles loaded with NT-3 changed from 1,039 m 2/g, 0.726 cm 3/g and 2.754 nm to 779 m 2/g, 0.403 cm 3/g and 1.903 nm, respectively. The hydrogel had a uniform internal microporous structure and good porosity so that it easily adhered to the spinal cord and achieved long-term stable release of NT-3 for at least 20 days. CCK-8 results showed that at 24 hours after the neural stem cells were laid, the cell proliferative activities in the 4%NT-3/SiO 2@CS and 6% NT-3/SiO 2@CS groups were significantly lower than that in the group untreated ( P<0.05). The immunofluorescence staining showed that the fluorescence intensity of glial fibrillary acidic protein (GFAP), the NSC marker in NT-3/SiO 2@CS, insignificantly decreased in the groups with different concentrations of NT-3/SiO 2@CS compared with the group untreated ( P>0.05). The fluorescence intensities of GFAP, MAP2 and GFAP/MAP2 in the NT-3/SiO 2@CS group were significantly higher than those in the other groups ( P<0.05). The BMS scoring for mice showed sham group>NT-3/SiO 2@CS group>SCI group and CS group for 8 weeks of modeling, and the response time of mice to cold and hot stimulations in the NT-3/SiO 2@CS group was significantly shorter than that in the SCI and CS groups. The differences above were statistically significant ( P<0.05). The Catwalk gait analysis showed that the hindlimb footprints in the NT-3/SiO 2@CS group were significantly clearer and more coherent than those in the SCI and CS groups. Conclusions:The sustained-release gel patch based on CS, SiO 2 and NT-3 has a uniform pore structure, good biocompatibility and excellent drug sustained-release effect. It can promote the differentiation of NSCs into neurons, thus contributing to recovery of motor and sensory functions after spinal cord injury.

Traumatic brain injury (TBI) involves both primary mechanical damage and refractory secondary injuries, resulting in high disability rate and poor prognosis. Current therapeutic strategies for TBI include surgical intervention, neuroprotective agents, moderate hypothermia therapy and spinal cord stimulation. However, most of these therapeutic approaches primarily address wound surface management rather than targeting specific pathogenic mechanisms underlying post-injury inflammation and neurodegenerative diseases, resulting in suboptimal efficacy. Consequently, novel therapeutic strategies targeting TBI pathological mechanisms are urgently needed. The endogenous cannabinoid system (ECS) exerts multifaceted neuroprotective effects in TBI by modulating neuroinflammation, inhibiting glutamate excitotoxicity and activating pathways such as phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt). Investigating the characteristics of ECS components and their related signaling pathways may yield new approaches in the development of neuroprotective drugs for TBI. Nevertheless, few ESC-targeting drugs for TBI treatment have advanced beyond preclinical or clinical trial phases. Breakthroughs in this field depend on a deeper understanding of ECS and its mechanisms in TBI. To this end, the authors reviewed researches on the composition and functions of ECS, as well as the mechanisms underlying its neuroprotective effects following TBI, aiming to provide references for the development of ECS-targeting therapies.

Objective:To explore the effect of mesoporous silica (SiO 2) chitosan (CS) hydrogel loaded with neurotrophin-3 (NT-3) on repair of spinal cord injury. Methods:After 2%, 4%, and 6% NT-3/SiO 2 were dissolved in CS solution, they were added into β-glycerophosphate sodium solution for chemical cross-linking to obtain hydrogel patches of different NT-3 loadings. The specific surface area, pore size and pore volume of mesoporous SiO 2 nanoparticles were detected by specific surface area analyzer. The morphology of mesoporous SiO 2 nanoparticles and the pore structure of freeze-dried hydrogel were detected by scanning electron microscopy. Adhesion of the hydrogel was verified by spinal cord tissue. After the NT-3/SiO 2@CS hydrogel was placed in the medium, the concentrations of NT-3 were measured for 1 to 20 days. Neural stem cells (NSCs) were isolated from fetal rats and identified. Cell counting kit 8 (CCK-8) assay was used to detect the proliferation of NSCs treated with different concentrations of hydrogel. Immunofluorescence staining was used to detect the effects of NT-3/SiO 2@CS hydrogel on differentiation of NSCs. Twenty-four 8-week-old C57BL/6JNifdc female mice were randomly divided into a sham operation group (sham), a spinal cord injury group (SCI), a chitosan hydrogel group (CS) and a mesoporous SiO 2-loaded NT-3 hydrogel group (NT-3/SiO 2@CS). In the sham group, the muscle and skin were sutured immediately after laminectomy without spinal cord injury. The CS hydrogel and NT-3/SiO 2@CS hydrogel patches were implanted without treatment after spinal cord injury in the other 3 groups, respectively. Basso Mouse Scale (BMS) was used to evaluate the mice every 7 days for 8 weeks after modeling. The hot and cold board test and Catwalk gait analysis were performed at 8 weeks after surgery. Results:The mesoporous SiO 2 nanoparticles showed typical spherical morphology and a uniform particle size (about 160 nm). The specific surface area, pore volume and pore size of the mesoporous SiO 2 nanoparticles loaded with NT-3 changed from 1,039 m 2/g, 0.726 cm 3/g and 2.754 nm to 779 m 2/g, 0.403 cm 3/g and 1.903 nm, respectively. The hydrogel had a uniform internal microporous structure and good porosity so that it easily adhered to the spinal cord and achieved long-term stable release of NT-3 for at least 20 days. CCK-8 results showed that at 24 hours after the neural stem cells were laid, the cell proliferative activities in the 4%NT-3/SiO 2@CS and 6% NT-3/SiO 2@CS groups were significantly lower than that in the group untreated ( P<0.05). The immunofluorescence staining showed that the fluorescence intensity of glial fibrillary acidic protein (GFAP), the NSC marker in NT-3/SiO 2@CS, insignificantly decreased in the groups with different concentrations of NT-3/SiO 2@CS compared with the group untreated ( P>0.05). The fluorescence intensities of GFAP, MAP2 and GFAP/MAP2 in the NT-3/SiO 2@CS group were significantly higher than those in the other groups ( P<0.05). The BMS scoring for mice showed sham group>NT-3/SiO 2@CS group>SCI group and CS group for 8 weeks of modeling, and the response time of mice to cold and hot stimulations in the NT-3/SiO 2@CS group was significantly shorter than that in the SCI and CS groups. The differences above were statistically significant ( P<0.05). The Catwalk gait analysis showed that the hindlimb footprints in the NT-3/SiO 2@CS group were significantly clearer and more coherent than those in the SCI and CS groups. Conclusions:The sustained-release gel patch based on CS, SiO 2 and NT-3 has a uniform pore structure, good biocompatibility and excellent drug sustained-release effect. It can promote the differentiation of NSCs into neurons, thus contributing to recovery of motor and sensory functions after spinal cord injury.

Objective To explore the role of toll-like receptor (TLR)/nitric oxide (NO) pathway in cervical tumor with high risk human papillomavirus (hrHPV) infection.Methods (1)Study was based on 36 women with nonmalignantcervical tissue as control group and 36 women with squamous cell cervical cancer (SCC),all with hrHPV infection which were assessed by using 14 types hrHPV E6/E7 mRNA real-time PCR kit.The amount of NO was detected by Griess reaction,the expression of inducible nitric oxide synthase (iNOS) was detected by immunohistochemistry (IHC).The mRNA expression of TLR3,TLR4,TLR7,TLR8,TLR9,nuclear factor-κB (NF-κB) p65 and iNOS in control and SCC epithelium which was captured by laser capture microdissection (LCM) were determined.(2)The expressions of TLR4 in CaSki,HeLa and C33a were detected by cell immunofluorescence method.The mRNA and protein expression of TLR/NO pathway transduction molecules including TLR4,NF-κBp65 and iNOS in CaSki,HeLa and C33a cell lines were detected by real-time PCR and western blot.Results (1)The level of NO was much higher in SCC group than that in control group [(42.92±0.36) μmol/L vs (15.49±0.24) μmol/L;P＜0.05].iNOS was detected in 75％ (27 cases) of patients with squamous cervical carcinoma,while only 6％ (2 cases) of normal controls were confirmed with positve result (P＜0.05).TLR/NO pathway maybe activated in SCC,for the mRNA levels of TLR3,TLR4,TLR7,TLR8,NF-κBp65 and iNOS increased significantly when compared to control group (all P＜0.05),and the greatest change in the expression level of TLR in SCC was spotted on TLR4(7.41±0.39 vs 1.86±0.21).(2)The results of immunofluorescence showed that TLR4 was located at plasma membrance of hrHPV positive HeLa and CaSki cells,while the integral optical density of TLR4 in HeLa cells (3 599±427) or CaSki cells (2 080±456) were higher than that in C33a cells (730±96;P＜0.05).The mRNA and protein level of TLR4,NF-κBp65 and iNOS in HeLa and CaSki cells were higher than those of C33a cells (P＜0.05).Conclusion TLR4/NO pathway is highly expressed in cervical cancer with hrHPV infection,while the pathway may be involved in cervical tumorigenesis with hrHPV infection.

Objective: Evaluate the influence of monochrome LCDs with different resolutions for the quality of detail imaging and detection performance of lesions. Methods: 93 DR chest images were selected from PACS on-line, including 38 positive cases, 32 suspected cases and 23 normal cases. The positive cases were divided into two groups A and B according the diameter of pulmonary nodules. Three of high-, mid-and low-experienced radiologists interpreted the 93 images on three types of displays independently. Each observer marked their confidence of the presence of pulmonary nodule with five-point rating scale : (1)definitely absent, (2)probably absent, (3)possibly present, (4)probably present and (5)definitely present, and the visual quality of lung markings with three-point rating scale:(1) excellent, (2)free, (3) inferior. Software SPSS 13.0 was used to analyze the results. Results: For the detection performance of lesion, while detecting nodules of Group A, the areas under ROC curves were 0.643、0.686、0.739 on 2MP、3MP and 3MP display for high-experienced radiologist. Those were 0.636、0.682、0.717 for mid-experienced radiologist and 0.623、0.656、0.721 for low-experienced radiologist; while detecting nodules of Group B, those were 0.813、0.832、0.846 for high-experienced d radiologist, 0.773、0.824、0.838 for mid-experienced radiologist and 0.763、 0.7.73、0.833 for low-experienced radiologist. There were no significant differences among detection performance ofradiodiagnostic systems. For the quality of detail imaging, while interpreting the visualization of lung markings, the difference between high-and mid-experienced radiologist or between high-and low-experienced radiologist on 5MP display was conspicuous (P<0.05). But the differences of other comparisons did not reach the significant level. Conclusions: For the detection performance ofpulmouary nodules, it is comparable among different radiodiagnostic systems; for the visualization of lung markings, high-experienced radiologist could get more information on 5MP display.

With the rapid development of society and the increasing improvement of living standard,people shows increasing demand for high quality of medical care so that more and more advanced medical instruments are applied to disease prevention,diagnosis and treatment.Thanks to the development of the professional medical technology,a new branch of medicine-clinical engineering has emerged.The history,current situation and future development of clinical engineering are mainly expounded.

Fracture is the most serious complication caused by osteopor osis. Vertebral fracture in osteoporosis is a strong risk factor for new fractur es as well as an important parameter in prognosticating new fractures. As a stro ng risk factor, vertebral fracture reflects the degeneration of the structure of bone and the reduction of bone mineral density (BMD). Therefore, it is more val uable in predicting the risk of refracture when the reduction of BMD and vertebr al fracture is reflected. It is more convenient and easier to evaluate vertebral fracture by radiographic grading and semiquantitative grading scheme without me asuring the vertebral height. To evaluate the drugs for osteoporosis objectively and accurately, their effects on both BMD and vertebral fracture should be take n into consideration. The ideal drug should be one that can increase BMD and red uce the risk of vertebral fracture.

Objectiv e To evaluate the mid-term and long-term clinical outcome of total hip re-pl ace ment in patients with hip congenital dislocation.Methods From June198 3to Decem ber1998,36hips in32patients di agnosed as congenital disloca tion of hip(CDH),aged22to69years old(with the mean of 48.5years), were treated with total hip replacement (THR).Thirty-one hips of 28patient s were fol lowed-up with the duration of 9.5years(3.5to18years).Ac c ording to our system,the congen ital dys-pla sia of hip was divid ed into th ree degrees:the first degree was subluxation in15hips,the second degree was in termedi ate dislo cation in11hips,and the third degree was high dislocatio n in5hips.The fixation of the prosthetic compo nents was as follows :10cup s and12stems with cement,21cups and19stems with un-cement.In acetab ula r preparation,most of the patients with subluxation(13hips)underwent deep ening of the acetabu lum and were installed with larger cups;deepening of the acetabulum,smaller cup and auto femoral grafting on the su perior lip fixed w ith screws were performed in2hips with subluxation and all of hips with interm e di ate and high dislocation.Results The complications included intra operativ e lesser trochanter fracture in1case,deep vein thrombosis and thromboembolism of femoral artery in1case re spec-tively,limb discrepancy in3cases,asepti c loosening in4cases(1with trochanteric nonunion and migration,1with stem l oosening and2with both stem and cup loosening).The Harrisscore was85in th e other27hips(48scores before surgery).Con clusion Total hip replacement in patients with congenital dislocation of hip could be some what difficult be cause of the liability to complications.The techni cal difficulties en coun-t ered during surgery in cluded the correction of the length of bilateral lower extremi ty,the balance of the abductor muscles,the re lease of the soft tis sue,the dealing of the su perior segmental defect of acetabulum and selectio n of the compo nents.